E

Eshelman Ventures, LLC

0 employees

Eshelman Ventures, based in New Castle, provides investment to private healthcare companies.

Investor insights

Sectors invested in

Biotechnology14
Therapeutics10
Medical9
Health Care9
Pharmaceutical4
Biopharma3
Developer Platform2
Cancer / Oncology2
Drug Discovery and Development2
Medical Device2
Oncology2
Precision Oncology2
Precision Medicine2
Cancer2
Drug Discovery2
Biotechnology and Peptides2
3D Printing1
biopharmaceuticals1
Nanotechnology1
materials science1

Funding rounds participated in

$23M sweet spot round size

Most of their 15 investments are in rounds between $10M and $33M

Investor type

Venture Capital

Basic info

Sectors

Financial Services
Health Care
Venture Capital

Date founded

2014

Investments made

S

Sapience Therapeutics, Inc. raised $41M on May 31, 2022

Investors: Kingdon Capital Management, Bristol-Myers Squibb, UK and Eshelman Ventures, LLC

I

Incyclix Bio raised $30M on March 31, 2022

Investors: RA Capital Management, L.P. and Eshelman Ventures, LLC

A

Aravive, Inc. raised $10M on January 3, 2022

Investors: Eshelman Ventures, LLC

I

Incyclix Bio raised $6M on August 6, 2020

Investors: Eshelman Ventures, LLC

L

Liquidia Technologies raised $22M on December 26, 2019

Investors: Samsara BioCapital, Canaan and Eshelman Ventures, LLC

K

Kinnate Biopharma, Inc. raised $75M on December 19, 2019

Investors: Nextech Invest, Vida Ventures, LLC, Foresite Capital, OrbiMed Advisors and Eshelman Ventures, LLC

A

ArunA Biomedical, Inc. raised $13M on July 24, 2019

Investors: Eshelman Ventures, LLC

K

Kinnate Biopharma, Inc. raised $22M on April 1, 2018

Investors: Foresite Capital and Eshelman Ventures, LLC

S

Sapience Therapeutics, Inc. raised $23M on July 12, 2016

Investors: TaiAn Technologies Corporation, Celgene and Eshelman Ventures, LLC

G

G1 Therapeutics, Inc. raised $47M on May 11, 2016

Investors: Lumira Ventures, Mountain Group Partners, RA Capital Management, L.P., Tavistock Group, Cowen Inc. and Eshelman Ventures, LLC

FAQ